IDSA: New Treatment Offers Promise for Complicated UTIs
Meropenem-vaborbactam effective against carbapenem-resistant Enterobacteriaceae
Few Changes in Employer-Sponsored Insurance 2013-2014
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
Guidelines Presented for Fluoroquinolone Use in Children
Fluoroquinolones should be considered in specific situations when there is no safe, effective alternative
New Way Bacteria Can Trigger Inflammation in Acne Identified
Findings may lead to new avenues for treatment
Useful Tips Offered for Addressing Negative Patient Reviews
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
IDSA: Cranberry Capsules Don’t Appear to Help Prevent UTIs
In female nursing home residents, no significant effect on bacteriuria plus pyuria over one year
ISDA: U.S. Prevalence of Immunosuppression 2.7 Percent
Prevalence ranged from 1.8 to 3.1 percent; highest among women, whites, those aged 50 to 59 years
IDSA: Experimental Rx May Be Option in Drug-Resistant HIV
'This is potentially a lifesaving therapy,' researcher says
IDSA: Measles Complication SSPE More Common Than Thought
Clinicians to be aware of subacute sclerosing panencephalitis
HIV Active in Tissues Even in Patients on Antiretrovirals
Active, untreated virus in tissues could be driving diseases unrelated to AIDS
